VYGR vs ZURA

Voyager Therapeutics, Inc. vs Zura Bio Limited — Valuation Comparison 2026

VYGR

Biological Products, (No Diagnostic Substances)
Voyager Therapeutics, Inc.
Quality
5.6
out of 10
Value Trap
38
LOW
Price
$3.87
Last close
Models
9/13
Active
VS

ZURA

Biological Products, (No Diagnostic Substances)
Zura Bio Limited
Quality
4.9
out of 10
Value Trap
12
SAFE
Price
$4.30
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType VYGR Fair ValueVYGR Upside ZURA Fair ValueZURA Upside
Bayesian DCF Intrinsic $0.93 -75.9% $2.56 -40.4%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $3.21 -17.1% $2.60 -39.6%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for VYGR vs ZURA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

VYGR vs ZURA — Which Stock Is More Undervalued?

VYGR scores higher with a 5.6/10 quality rating vs ZURA's 4.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Voyager Therapeutics, Inc. (VYGR) and Zura Bio Limited (ZURA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

VYGR currently trades at $3.87 with a QOC of 5.6/10, while ZURA trades at $4.30 with a QOC of 4.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).